Relmada Therapeutics Inc (RLMD) - Multiplikator forward rega marang pendapatan
Relmada Therapeutics (RLMD) relies on outsourcing production and testing to maintain R&D flexibility. High barriers to entry are created by REL-1017 patents under strict FDA oversight. The company's fate is tied to the success of trials and the rate of capital expenditure. This forward price-to-sales chart visualizes these trends, and the current metric has reached the level of .
Rincian metrik komprehensif lan analitis Relmada Corp (RLMD)
- rega saham lan target rega konsensus:
- indikator kapitalisasi pasar:
- rincian valuasi buku bisnis:
- statistik kawajiban utang lan likuiditas:
Utang marang Ekuitas Relmada Therapeutics|RLMD - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Relmada Therapeutics|RLMD - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Relmada Corp|RLMD - Kewajiban jangka dawa|Utang jangka cendhak perusahaan Relmada Therapeutics|Indikator likuiditas cepet relmada.com
- rincian asil keuangan lan kelipatan valuasi:
RLMD - Bathi resik|Bathi mangsa ngarep Relmada Therapeutics|RLMD - Rasio rega pasar marang bathi resik|Pangali Forward P/E Relmada|RLMD - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Relmada Corp|RLMD - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Relmada Therapeutics|RLMD - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan relmada.com|RLMD - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Relmada Therapeutics
- statistik dodolan lan pendapatan perusahaan:
Analisis fundamental perusahaan:RLMD (Relmada Therapeutics, Inc.)
The dynamics of this multiple reflect market expectations regarding future sales and the business's ability to maintain its capitalization amid changing external conditions. Since Relmada Therapeutics (RLMD) is in the clinical trial stage and has no current revenue, the company's forward P/S chart demonstrates a speculative valuation of potential revenue, which currently depends entirely on the efficiency of raising external capital.
Pesaing langsung
Biogen - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan NBIX|RGC: Multiplikator forward rega marang pendapatan|Axsome Corp - Rasio rega marang pendapatan sing dikarepake|ACAD: Multiplikator Forward P/S|xenon-pharma.com - Rega forward marang dodolan|VKTX (Viking Therapeutics, Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Supernus Pharmaceuticals, Inc. SUPN|Rasio rega marang prakiraan pendapatan Catalyst Pharmaceuticals Inc (CPRX)|DNLI (Denali Corp) - Rega forward marang dodolan|Multiplikator Forward P/S HRMY (Harmony Biosciences)|Multiplikator Forward P/S biohavenpharma.com BHVN|AMLX - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TRVI|PRAX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Anavex Life Sciences Corp (AVXL)|Multiplikator forward rega marang pendapatan CBLL|Multiplikator Forward P/S Prothena Corporation|Multiplikator forward rega marang pendapatan ALEC (Alector, Inc.)|Rasio rega marang pendapatan sing dikarepake ANNX|Multiplikator Forward P/S OMER (Omeros)|Rasio kapitalisasi marang dodolan sing dikarepake Neurogene Therapeutics (NGNE)|AC Immune - Multiplikator Forward P/S|voyagertherapeutics.com (VYGR) - Multiplikator forward rega marang pendapatan|Neumora Therapeutics, Inc. (NMRA) - Rasio rega marang prakiraan pendapatan|SCLX - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Tevogen Bio Holdings, Inc.|ACOG: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Cognition Therapeutics (CGTX)|Rasio rega marang prakiraan pendapatan IKT (inhibikase.com)|Rasio rega marang prakiraan pendapatan Cassava Sciences SAVA|ASRT - Multiplikator forward rega marang pendapatan|Coya - Multiplikator Forward P/S|VTGN (Vistagen Therapeutics) - Kapitalisasi marang prakiraan pendapatan|ovidrx.com (OVID) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan ABOS|CRVO (CervoMed) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Alterity Therapeutics Ltd ATHE|Multiplikator forward rega marang pendapatan CLNN (Clene Inc.)|Multiplikator Forward P/S pepgen.com (PEPG)|Rasio rega marang prakiraan pendapatan Jupiter Neurosciences Inc JUNS|Rega forward marang dodolan ANVS|GRCE - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Firefly Neuroscience, Inc.|anewmeds.com (KLTO) - Rasio rega marang prakiraan pendapatan|NeuroSense Therapeutics Ltd. - Rega forward marang dodolan|RVPH (Reviva Pharmaceuticals) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep MetaVia, Inc. MTVA|Rasio rega marang prakiraan pendapatan NeurAxis (NRXS)|Rasio rega marang prakiraan pendapatan HSDT (heliusmedical.com)|Rasio rega marang prakiraan pendapatan Passage Bio PASG|NEUP - Multiplikator forward rega marang pendapatan|Minerva Neurosciences - Multiplikator Forward P/S|ATHA - Multiplikator Forward P/S|ADXN: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan ALZN|CYCN (Cyclerion Therapeutics Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S Protagenic|Multiplikator forward rega marang pendapatan KTTA (Pasithea Therapeutics)|CRGT (cortigent.com) - Rega forward marang dodolan|Avenue Therapeutics, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc - Multiplikator Forward P/S|Rega forward marang dodolan CHRO (Chromocell)|ELYM: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Intra-Cellular Therapies, Inc. (ITCI)|Rasio rega marang prakiraan pendapatan Longboard Pharmaceuticals, Inc.|MRNS: Rega forward marang dodolan|Multiplikator Forward P/S NKGN|Multiplikator Forward P/S NeuroBo Pharma (NRBO)|Rasio rega marang prakiraan pendapatan Sage Therapeutics, Inc. SAGE|SNPX (synaptogen.com) - Rega mangsa ngarep marang pendapatan|Trevena - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Vigil Neuroscience|WENA (Anew Medical) - Multiplikator forward rega marang pendapatan|Cerevel Corp (CERE) - Multiplikator Forward P/S
